Move from scientific strategy to decision-ready data and submission-ready evidence
Veristat is a specialty CRO for complex Phase I-III clinical development. We help biotech and specialty pharma sponsors connect advisory, BSP delivery, clinical operations, regulatory strategy and medical writing so complex programs move from scientific strategy to decision-ready data and submission-ready evidence.
Veristat BSP delivery turns clinical data into decision-ready evidence through biostatistics, statistical programming, data management, standards and InStat-enabled TLF automation.
Veristat delivers complex Phase I-III clinical trials where patient populations, endpoints, sites, timelines and evidence requirements demand more than capacity.
Veristat connects regulatory strategy, medical writing, regulatory writing, editing and publishing so the evidence story holds together before submission pressure hits.
Veristat partners with sponsors to shape study design, endpoints, development strategy and regulatory path before capital, timelines and patient trust are put at risk.
